Cargando…
Genetic Aberrations and Interaction of NEK2 and TP53 Accelerate Aggressiveness of Multiple Myeloma
It has been previously shown that (never in mitosis gene A)‐related kinase 2 (NEK2) is upregulated in multiple myeloma (MM) and contributes to drug resistance. However, the mechanisms behind this upregulation remain poorly understood. In this study, it is found that amplification of NEK2 and hyperme...
Autores principales: | Feng, Xiangling, Guo, Jiaojiao, An, Gang, Wu, Yangbowen, Liu, Zhenhao, Meng, Bin, He, Nihan, Zhao, Xinying, Chen, Shilian, Zhu, Yinghong, Xia, Jiliang, Li, Xin, Yu, Zhiyong, Li, Ruixuan, Ren, Guofeng, Chen, Jihua, Wu, Minghua, He, Yanjuan, Qiu, Lugui, Zhou, Jiaxi, Zhou, Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948659/ https://www.ncbi.nlm.nih.gov/pubmed/35088582 http://dx.doi.org/10.1002/advs.202104491 |
Ejemplares similares
-
NEK2 induces autophagy‐mediated bortezomib resistance by stabilizing Beclin‐1 in multiple myeloma
por: Xia, Jiliang, et al.
Publicado: (2020) -
High NEK2 confers to poor prognosis and contributes to cisplatin‐based chemotherapy resistance in nasopharyngeal carcinoma
por: Xu, He, et al.
Publicado: (2018) -
Excessive serine from the bone marrow microenvironment impairs megakaryopoiesis and thrombopoiesis in Multiple Myeloma
por: Kuang, Chunmei, et al.
Publicado: (2023) -
Blocking glycine utilization inhibits multiple myeloma progression by disrupting glutathione balance
por: Xia, Jiliang, et al.
Publicado: (2022) -
Cdc37 suppression induces plasma cell immaturation and bortezomib resistance in multiple myeloma via Xbp1s
por: Zang, Meirong, et al.
Publicado: (2020)